Business Context and Reporting Period
Company: Can-Fite Biopharma Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: March 24, 2022
Reporting Period: The filing incorporates by reference a press release announcing financial results for the year ended December 31, 2021.
Key Financial Metrics
The provided text serves as a cover document incorporating a press release by reference. It does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. The filing text does not provide a clear value for these metrics.
Material Changes
No material changes or comparative financial data are detailed within the provided text. The document only confirms the issuance of the 2021 annual results press release.
Guidance, Outlook, and Risks
The filing incorporates "Forward Looking Statements" from the attached press release (Exhibit 99.1) by reference. However, the specific content of the guidance, outlook, management commentary, risks, contingencies, or unusual items is not present in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 24, 2022) for actual financial figures and operational updates.
- Verify the specific details of the "Forward Looking Statements" incorporated by reference.
- Confirm the company's cash position and burn rate from the full 2021 financial statements referenced in the press release.
- Check for any updates on clinical trial progress or regulatory milestones not summarized in this cover letter.